Genmab A/S
NASDAQ:GMAB

Watchlist Manager

Genmab A/S

NASDAQ:GMAB

Watchlist

Dividends

Price: 20.65 USD 0.88% Market Closed

Market Cap: 13.1B USD

Have any thoughts about
Genmab A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

Add Price Alert

Price Target:

Last Price: 20.65 USD

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

GMAB Alert

Genmab A/S

20.65

+0.18 (+0.88%)

52 Week Range	20.45 32.77
Price Target

We'll email you a reminder when the closing price reaches USD.

Save Alert

Choose the stock you wish to monitor with a price alert.

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

Genmab A/S

What unique competitive advantages
does Genmab A/S hold over its rivals?

What risks and challenges
does Genmab A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of Genmab A/S.

What unique competitive advantages
does Genmab A/S hold over its rivals?

What risks and challenges
does Genmab A/S face in the near future?

Summarize the latest earnings call
of Genmab A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Genmab A/S.

Provide P/S
for Genmab A/S.

Provide P/E
for Genmab A/S.

Provide P/OCF
for Genmab A/S.

Provide P/FCFE
for Genmab A/S.

Provide P/B
for Genmab A/S.

Provide EV/S
for Genmab A/S.

Provide EV/GP
for Genmab A/S.

Provide EV/EBITDA
for Genmab A/S.

Provide EV/EBIT
for Genmab A/S.

Provide EV/OCF
for Genmab A/S.

Provide EV/FCFF
for Genmab A/S.

Provide EV/IC
for Genmab A/S.

Show me price targets
for Genmab A/S made by professional analysts.

What are the Revenue projections
for Genmab A/S?

How accurate were the past Revenue estimates
for Genmab A/S?

What are the Net Income projections
for Genmab A/S?

How accurate were the past Net Income estimates
for Genmab A/S?

What are the EPS projections
for Genmab A/S?

How accurate were the past EPS estimates
for Genmab A/S?

What are the EBIT projections
for Genmab A/S?

How accurate were the past EBIT estimates
for Genmab A/S?

Compare the revenue forecasts
for Genmab A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Genmab A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Genmab A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Genmab A/S compared to its peers.

Compare the P/E ratios
of Genmab A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Genmab A/S with its peers.

Analyze the financial leverage
of Genmab A/S compared to its main competitors.

Show all profitability ratios
for Genmab A/S.

Provide ROE
for Genmab A/S.

Provide ROA
for Genmab A/S.

Provide ROIC
for Genmab A/S.

Provide ROCE
for Genmab A/S.

Provide Gross Margin
for Genmab A/S.

Provide Operating Margin
for Genmab A/S.

Provide Net Margin
for Genmab A/S.

Provide FCF Margin
for Genmab A/S.

Show all solvency ratios
for Genmab A/S.

Provide D/E Ratio
for Genmab A/S.

Provide D/A Ratio
for Genmab A/S.

Provide Interest Coverage Ratio
for Genmab A/S.

Provide Altman Z-Score Ratio
for Genmab A/S.

Provide Quick Ratio
for Genmab A/S.

Provide Current Ratio
for Genmab A/S.

Provide Cash Ratio
for Genmab A/S.

What is the historical Revenue growth
over the last 5 years for Genmab A/S?

What is the historical Net Income growth
over the last 5 years for Genmab A/S?

What is the current Free Cash Flow
of Genmab A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Genmab A/S.

EV/GP
Enterprise Value to Gross Profit

4.3

Current

4.5

Median

Industry

Lower than median

Lower than industry value

All Countries

Forward Multiples

			Market Cap	EV/GP
DK		Genmab A/S NASDAQ:GMAB	94.2B USD	4.3
FR		Pharnext SCA OTC:PNEXF	6T USD	0
US		Abbvie Inc NYSE:ABBV	312.7B USD	9.7
US		Amgen Inc NASDAQ:AMGN	158.3B USD	10.5
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	116.2B USD	11.9
US		Gilead Sciences Inc NASDAQ:GILD	112.4B USD	4.9
US	E	Epizyme Inc F:EPE	94.1B EUR	2 451.4
AU		CSL Ltd ASX:CSL	133.6B AUD	12.6
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	81.3B USD	6.2
US	S	Seagen Inc F:SGT	39.3B EUR	22.9
NL		argenx SE XBRU:ARGX	34.8B EUR	19.1


DK		Genmab A/S NASDAQ:GMAB	Average EV/GP: 255.3 4.3
FR		Pharnext SCA OTC:PNEXF	Not Available
US		Abbvie Inc NYSE:ABBV	9.7
US		Amgen Inc NASDAQ:AMGN	10.5
US		Vertex Pharmaceuticals Inc NASDAQ:VRTX	11.9
US		Gilead Sciences Inc NASDAQ:GILD	4.9
US	E	Epizyme Inc F:EPE	2 451.4
AU		CSL Ltd ASX:CSL	12.6
US		Regeneron Pharmaceuticals Inc NASDAQ:REGN	6.2
US	S	Seagen Inc F:SGT	22.9
NL		argenx SE XBRU:ARGX	19.1

EV/GP Forward Multiples

Forward EV/GP multiple is a version of the EV/GP ratio that uses forecasted gross profit for the EV/GP calculation. 1-Year, 2-Years, and 3-Years forwards use gross profit forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/GP

N/A

2-Years Forward

EV/GP

N/A

3-Years Forward

EV/GP

N/A

Genmab A/S
NASDAQ:GMAB

EV/GP
Enterprise Value to Gross Profit

EV/GP Forward Multiples

See Also

Company

Help

Tools

Stocks

Genmab A/S NASDAQ:GMAB

EV/GP Enterprise Value to Gross Profit

EV/GP Forward Multiples

See Also

Company

Help

Tools

Stocks

Genmab A/S
NASDAQ:GMAB

EV/GP
Enterprise Value to Gross Profit